BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Advanced Therapies Wales - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://advancedtherapieswales.co.uk
X-WR-CALDESC:Events for Advanced Therapies Wales
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260916T093000
DTEND;TZID=Europe/London:20260916T163000
DTSTAMP:20260804T074252Z
CREATED:20260804T074252Z
LAST-MODIFIED:20260804T074252Z
UID:695-1789551000-1789576200@advancedtherapieswales.co.uk
SUMMARY:Cardiff Cancer Research Partnership Annual Event 2026
DESCRIPTION:Join us for the Cardiff Cancer Research Partners (CCRP) Annual Conference 2026\, bringing together researchers\, clinicians\, students and partners from across the cancer research community for a day of knowledge sharing\, collaboration and networking. \nThe conference will showcase the breadth of cancer research taking place across Cardiff and Wales\, with presentations covering clinical research\, discovery science\, translational research\, drug development\, precision medicine and data strategy. Attendees will hear from leading experts and emerging researchers\, gain insight into current and future research priorities\, and explore opportunities to build new partnerships that accelerate progress in cancer care and research. \nThe event will also feature exhibitor stands from organisations across the cancer research landscape\, providing opportunities to connect with colleagues\, discover new initiatives and discuss future collaborations. \nWhether you are actively involved in cancer research\, support research delivery\, or are interested in the future direction of cancer care in Wales\, this conference offers a valuable opportunity to engage with the wider cancer research community. \nWho should attend? \n\nResearchers and academics\nClinicians and healthcare professionals\nResearch nurses and allied health professionals\nStudents and early career researchers\nResearch partners\, charities and industry representatives\nAnyone with an interest in advancing cancer research in Wales\n\nTickets are free – Register here
URL:https://advancedtherapieswales.co.uk/event/cardiff-cancer-research-partnership-annual-event-2026/
LOCATION:Hadyn Ellis Building\, Cardiff
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://advancedtherapieswales.co.uk/wp-content/uploads/2026/08/CCRP-web.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260916T160000
DTEND;TZID=Europe/London:20260916T170000
DTSTAMP:20260804T115238Z
CREATED:20260804T115238Z
LAST-MODIFIED:20260804T115238Z
UID:734-1789574400-1789578000@advancedtherapieswales.co.uk
SUMMARY:Transitioning to serum-free T cell manufacturing: process considerations and cross-platform scale-up data
DESCRIPTION:Serum is one of the largest sources of variability in T cell manufacturing\, driving lot-to-lot inconsistency\, sourcing constraints\, and contamination risk. This data-led session shows you how a chemically defined\, serum-free workflow removes that dependency\, so you can build more reproducible processes from early development through clinical scale. \nChengkang Zhang will walk through experimental data on the impact of serum removal at each stage of manufacturing: improved lentiviral vector transduction efficiency\, robust T cell expansion in serum-free culture\, and clinical-scale performance across multiple platforms. You will see cross-platform results spanning T-flasks\, G-Rex\, Xuri\, and Cocoon systems\, plus practical evidence on how oxygen transfer and media exchange strategies shape expansion outcomes. \nAttend this webinar to: \n\nTake away a data-backed framework for evaluating and implementing serum-free T cell culture in your own workflows\nSee experimental data showing improved lentiviral vector transduction efficiency and consistent expansion after serum removal\nCompare cross-platform scale-up performance across T-flasks\, G-Rex\, Xuri\, and Cocoon systems\, from research through clinical manufacturing\nLearn the critical success factors that determine a successful transition\, including cell handling\, media management\, and dissolved oxygen control\n\nChengkang (CK) Zhang\, Associate Director\, R&D\, Lonza\, brings extensive experience in mammalian cell culture and chemically defined media development for cell therapy\, and is the inventor of several cell culture technology patents. \nFind out more
URL:https://advancedtherapieswales.co.uk/event/transitioning-to-serum-free-t-cell-manufacturing-process-considerations-and-cross-platform-scale-up-data/
LOCATION:Online
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://advancedtherapieswales.co.uk/wp-content/uploads/2026/08/Lonza-webinar-web.png
END:VEVENT
END:VCALENDAR